Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF)
USD 56.04
(14.37%)
USD 56.04
(14.37%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 1.86 EUR | 24.34% |
| 2022 | 1.52 EUR | -18.72% |
| 2021 | 1.87 EUR | 8.09% |
| 2020 | 1.73 EUR | -3.89% |
| 2019 | 1.80 EUR | 17.65% |
| 2018 | 1.53 EUR | 9.29% |
| 2017 | 1.40 EUR | 21.74% |
| 2016 | 1.15 EUR | 18.56% |
| 2015 | 0.97 EUR | 22.78% |
| 2014 | 0.79 EUR | 19.7% |
| 2013 | 0.66 EUR | 11.86% |
| 2012 | 0.59 EUR | 1.72% |
| 2011 | 0.58 EUR | 5.45% |
| 2010 | 0.55 EUR | -1.79% |
| 2009 | 0.56 EUR | 9.8% |
| 2008 | 0.51 EUR | 18.6% |
| 2007 | 0.43 EUR | 16.22% |
| 2006 | 0.37 EUR | 12.12% |
| 2005 | 0.33 EUR | 22.22% |
| 2004 | 0.27 EUR | 125.0% |
| 2003 | 0.12 EUR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 0.60 EUR | 46.34% |
| 2024 Q2 | 0.49 EUR | -18.33% |
| 2023 Q4 | 0.41 EUR | 10.81% |
| 2023 Q2 | 0.50 EUR | -16.67% |
| 2023 Q1 | 0.60 EUR | 71.43% |
| 2023 Q3 | 0.37 EUR | -26.0% |
| 2023 FY | - EUR | 24.34% |
| 2022 Q3 | 0.44 EUR | 62.96% |
| 2022 FY | - EUR | -18.72% |
| 2022 Q1 | 0.47 EUR | 9.3% |
| 2022 Q2 | 0.27 EUR | -42.55% |
| 2022 Q4 | 0.35 EUR | -20.45% |
| 2021 Q1 | 0.44 EUR | 12.82% |
| 2021 Q4 | 0.43 EUR | 0.0% |
| 2021 Q3 | 0.43 EUR | -24.56% |
| 2021 FY | - EUR | 8.09% |
| 2021 Q2 | 0.57 EUR | 29.55% |
| 2020 Q4 | 0.39 EUR | 2.63% |
| 2020 FY | - EUR | -3.89% |
| 2020 Q1 | 0.54 EUR | -3.57% |
| 2020 Q2 | 0.42 EUR | -22.22% |
| 2020 Q3 | 0.38 EUR | -9.52% |
| 2019 Q3 | 0.39 EUR | -2.5% |
| 2019 FY | - EUR | 17.65% |
| 2019 Q4 | 0.56 EUR | 43.59% |
| 2019 Q1 | 0.45 EUR | 21.62% |
| 2019 Q2 | 0.40 EUR | -11.11% |
| 2018 FY | - EUR | 9.29% |
| 2018 Q4 | 0.37 EUR | 2.78% |
| 2018 Q3 | 0.36 EUR | -2.7% |
| 2018 Q2 | 0.37 EUR | -11.9% |
| 2018 Q1 | 0.42 EUR | 27.27% |
| 2017 Q1 | 0.38 EUR | 40.74% |
| 2017 Q2 | 0.33 EUR | -13.16% |
| 2017 Q3 | 0.35 EUR | 6.06% |
| 2017 FY | - EUR | 21.74% |
| 2017 Q4 | 0.33 EUR | -5.71% |
| 2016 Q4 | 0.27 EUR | -6.9% |
| 2016 Q1 | 0.32 EUR | 39.13% |
| 2016 Q2 | 0.28 EUR | -12.5% |
| 2016 Q3 | 0.29 EUR | 3.57% |
| 2016 FY | - EUR | 18.56% |
| 2015 Q4 | 0.23 EUR | -4.17% |
| 2015 Q1 | 0.25 EUR | 38.89% |
| 2015 Q2 | 0.25 EUR | 0.0% |
| 2015 Q3 | 0.24 EUR | -4.0% |
| 2015 FY | - EUR | 22.78% |
| 2014 FY | - EUR | 19.7% |
| 2014 Q2 | 0.20 EUR | -4.76% |
| 2014 Q4 | 0.18 EUR | -10.0% |
| 2014 Q3 | 0.20 EUR | 0.0% |
| 2014 Q1 | 0.21 EUR | 31.25% |
| 2013 Q4 | 0.16 EUR | 6.67% |
| 2013 Q2 | 0.16 EUR | -15.79% |
| 2013 Q1 | 0.19 EUR | 46.15% |
| 2013 FY | - EUR | 11.86% |
| 2013 Q3 | 0.15 EUR | -6.25% |
| 2012 Q1 | 0.17 EUR | 0.0% |
| 2012 Q2 | - EUR | -100.0% |
| 2012 Q3 | 0.15 EUR | 0.0% |
| 2012 Q4 | 0.13 EUR | -13.33% |
| 2012 FY | - EUR | 1.72% |
| 2011 Q4 | - EUR | 0.0% |
| 2011 FY | - EUR | 5.45% |
| 2011 Q1 | 0.16 EUR | 0.0% |
| 2011 Q2 | - EUR | -100.0% |
| 2011 Q3 | - EUR | 0.0% |
| 2010 Q4 | - EUR | 0.0% |
| 2010 Q2 | - EUR | -100.0% |
| 2010 FY | - EUR | -1.79% |
| 2010 Q3 | - EUR | 0.0% |
| 2010 Q1 | 0.15 EUR | 0.0% |
| 2009 FY | - EUR | 9.8% |
| 2009 Q1 | 0.14 EUR | 0.0% |
| 2009 Q2 | - EUR | -100.0% |
| 2009 Q4 | - EUR | 0.0% |
| 2009 Q3 | - EUR | 0.0% |
| 2008 FY | - EUR | 18.6% |
| 2007 FY | - EUR | 16.22% |
| 2006 FY | - EUR | 12.12% |
| 2005 FY | - EUR | 22.22% |
| 2004 FY | - EUR | 125.0% |
| 2003 FY | - EUR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| AstraZeneca PLC | 3.84 USD | 51.563% |
| Bristol-Myers Squibb Company PFD CONV 2 | 3.88 USD | 52.062% |
| CSPC Pharmaceutical Group Limited | 0.07 USD | -2557.143% |
| Clarus Therapeutics Holdings, Inc. | -8.04 USD | 123.134% |
| Novartis AG | 7.63 USD | 75.623% |
| PT Kalbe Farma Tbk. | 0.00 USD | -47592.308% |